Coronary Artery Bypass Graft Market Is Projected To Witness Growth Based On Increasing In Prevalence Of Cardiovascular Diseases Till 2025:Grand View Research,inc.

The global coronary artery bypass graft (CABG) market is expected to reach USD 127.6 million by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of Cardiovascular Diseases (CVDs) such as Coronary Artery Disease (CAD) or Coronary Heart Disease (CHD) coupled with rising geriatric population across the globe.

Favorable reimbursement policies, such as the U.S. Medicare (federal health insurance program) system, Medicaid, and National Health Insurance (NHI) have been a prime growth factor for the CABG market. Medical device companies provide new product platforms, which are covered under reimbursement programs that benefit the patients. Reimbursement services provided by Medicare and other insurers to physicians and hospitals is expected to fuel the demand for the adoption of CABG devices such as catheters, cannulae, retractors, positioners & stabilizers, suction devices, and syringes during the forecast period.

Browse full research report on Coronary Artery Bypass Graft Market: http://www.grandviewresearch.com/industry-analysis/coronary-artery-bypass-graft-cabg-market

Further Key Findings from the Study Suggest:

  • The saphenous vein grafts segment held a profitable revenue share in 2016 and is anticipated to grow at a significant rate over the forecast period
  • The off-pump CABG segment is anticipated to witness the fastest growth over the forecast period owing to the benefits offered by this technology such as increased safety, effective, reduced chances of bleeding during the surgery, low chances of stroke, low need for blood transfusions, low injury to the heart muscle, and improved quality of life
  • The endoscopic vein harvesting segment is expected to gain the market share over the forecast period as it eliminates the requirement for long incisions associated with open (conventional) harvesting, resulting in reducing the risk of wound infection and other complications, minimizing postoperative pain, and increasing the patient satisfaction level
  • North America is expected to dominate the CABG market during the forecast period, owing to the rising prevalence of CVDs in the U.S. and Canada. In addition, increasing per capita healthcare spending and growing population in the region are expected to spur the growth of this vertical.
  • Some of the key players of this market are Medtronic; TERUMO CORPORATION; Guidant Group; MAQUET Holding B.V. & Co.KG; Vitalitec International, Inc.; Novadaq Technologies Inc.; KARL STORZ GmbH & Co. KG; Edwards Lifesciences; Genesee Biomedical Inc.; and Sorin Group
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices  

Grand View Research has segmented the global CABG market on the basis of type, surgical procedure, technology, technique, and region:

CABG Market: Type Outlook (Revenue, USD Million, 2014 - 2025)
  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other
    • Radial Artery
    • Gastroepiploic Artery
CABG Market: Procedure Outlook (Revenue, USD Million, 2014 - 2025)
  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery
CABG Market: Technology Outlook (Revenue, USD Million, 2014 - 2025)
  • On-Pump CABG
  • Off-Pump CABG
CABG Market: Technique Outlook (Revenue, USD Million, 2014 - 2025)
  • Conventional Vessel Harvesting
  • Endoscopic Vessel Harvesting
CABG Market: Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more